Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MBOT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Defensive Investor Call to Address Third-party Article (new) — Company scheduling emergency call to rebut critical article suggests material negative claims requiring public response
Microbot Medical schedules call to rebut third-party article, discuss LIBERTY System rollout
Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read
Key Changes
-
high
Company will hold May 18 call to address misrepresentations in recent unaffiliated third-party article about LIBERTY System and provide Full Market Release update
Item 7.01 — Regulation FD Disclosure verify on EDGAR → -
high
Wall Street research firm published report refuting third-party article claims; report includes vascular surgeon disputing assertions attributed to him
Exhibit 99.1 view on EDGAR → -
medium
Two LIBERTY System users—Dr. Charles Briggs (Tampa General) and Dr. Zachary Bercu (Emory Healthcare)—will participate to share clinical experience
Exhibit 99.1 view on EDGAR →
Summary
Microbot Medical announced a May 18 conference call to address what it characterizes as misrepresentations in a recent third-party article about the company and its LIBERTY Endovascular Robotic System. The call will also provide an update on the Full Market Release of LIBERTY.
A Wall Street research firm has published a report refuting the article's claims, and the report includes statements from a vascular surgeon disputing assertions attributed to him in the original piece. The defensive posture is notable. Two physicians who use LIBERTY in clinical practice—Dr. Charles Briggs from Tampa General Hospital and Dr.
Zachary Bercu from Emory Healthcare—will participate to share their experience with the device. Dr. Briggs will specifically address inaccuracies attributed to him in the third-party article. The need for an expedited investor call with physician testimonials suggests the article raised concerns material enough to warrant immediate rebuttal. Investors should listen for specifics on what claims the company disputes and assess whether the physician testimony and Wall Street research adequately address the article's substance.
Section-by-Section Diff
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Dr. Charles Briggs, a vascular surgeon and one of the users of the LIBERTY System at Tampa General Hospital, will share his own experience with the LIBERTY System. Dr. Briggs will also address certain inaccuracies attributed to him, which were recently made by an unaffiliated third party in their article. Dr. Zachary L. Bercu, an interventional radiologist with Emory Healthcare and professor in the Division of Interventional Radiology and Image-Guided Medicine at Emory University School of Medicine, and the first user of the LIBERTY System, will also join and discuss the experience of utilizing the LIBERTY System in the everyday practice of their interventional radiology department.
Two physicians who use the LIBERTY System will participate in the conference call. Dr. Charles Briggs from Tampa General Hospital will discuss his experience and address inaccuracies attributed to him in the third-party article. Dr. Zachary Bercu from Emory Healthcare, the first user of the LIBERTY System, will discuss his department's experience with the device.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 11, 2026 · How we verify